SURFsara, the Dutch national ICT organisation providing state of the art services and support to thousands of researchers in the Netherlands, joined EUDAT Ltd as a new shareholder in January 2019.
As active member of the EUDAT CDI, SURFsara has focused recently in productising B2HANDLE - EUDAT’s service for registering research data, and B2SAFE - a service to distribute and store large volumes of data based on data policies - and now offers these two services as part of EUDAT Ltd portfolio.
Joining EUDAT Ltd as a shareholder represented a natural step for the Dutch organisation:
"SURFsara has been involved in building the European e-infrastructure since the early beginnings. Through this shareholder ship we affirm our belief and commitment to the European Collaborative Data Infrastructure initiative and - at the same time - it enables us to provide EUDAT data services to the benefit of Dutch and international institutions and researchers, which is highly motivating and rewarding.“ says Mark Huys, Unit Manager for Data Services at SURFsara, and a newly appointed member of the EUDAT Ltd Board of Directors.
“We are very pleased to welcome SURFsara as a shareholder", says Per Öster, Chairman of the Board of Directors of EUDAT Ltd. "SURFsara has a long track record in supporting science in the Netherlands, and delivering professional ICT services for research. It is an important step in the consolidation of EUDAT Ltd as an efficient and trustworthy partner for the years to come. That SURFsara become a shareholder demonstrates the importance for major EUDAT service providers to take part in governing and develop the common business processes and formulation of service offerings."
SURFsara offers specialised services in the field of High Performance Computing (HPC), Data Services, Visualization and Cloud Services, and is home to the national supercomputer Cartesius. The system is used for research areas, such as sustainable energy, climate change, water management, product and process optimization, reduction of noise pollution and improvement of medical treatments.